Waterdrop Inc. reported second quarter 2026 net operating revenue of RMB1,448.2 million (US$213.4 million), a 72.8% year-over-year increase driven by an 80.5% rise in insurance-related income to RMB1,333.2 million. Operating profit reached RMB111.3 million (US$16.4 million), up 14.3% year-over-year, while net profit attributable to ordinary shareholders was RMB125.8 million (US$18.5 million). The board approved a cash dividend of US$0.03 per ADS or US$0.003 per ordinary share, totaling approximately US$10.8 million, with a record date of October 9, 2026 and payment expected around November 3-6, 2026. Additionally, the board authorized a new US$50 million share repurchase program valid through September 10, 2027. Waterdrop Inc. operates as a technology platform dedicated to insurance brokerage, medical crowdfunding, and digital clinical trial solutions in China.

Ms. Xiaoying Xu resigned from her positions as vice president of finance and head of finance at Waterdrop Inc., effective July 31, 2026. The resignation was attributed to personal reasons and did not involve any disputes or disagreements regarding the company's operations, policies, or practices. Waterdrop Inc. is an insurance technology company.

Waterdrop Inc. announced the appointment of a new independent director. Waterdrop Inc. is an insurance technology platform company.

Waterdrop Inc. announced its unaudited financial results for the first quarter of 2026. The filing serves as a formal report of the company's quarterly performance. Waterdrop Inc. is an insurance technology company providing insurance brokerage and health management services.